FDA compresses drug review timelines in new national priority initiative The FDA’s National Priority Voucher program aims to cut standard review times from potentially years to months, raising questions about safety, access, and public health impact.

https://www.drugdiscoverynews.com/fda-compresses-drug-review-timelines-in-new-national-priority-initiative-16908